Boothbay Fund Management, LLC Jazz Pharmaceuticals PLC Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $2.35 Million - $2.86 Million	-19,632 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $963,127 - $1.38 Million	7,487 Added 61.65%	19,632 $2.56 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $1.95 Million - $2.26 Million	12,145 New	12,145 $2.16 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $377,427 - $436,005	-2,513 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $353,604 - $414,770	2,513 New	2,513 $415,000
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $439,721 - $550,455	-3,005 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $407,447 - $472,265	3,005 New	3,005 $454,000

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.88B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.